For a 70‑year‑old patient with diabetes using a Humalog (insulin lispro) U‑100 pen, injecting 6–14 units subcutaneously before each of three daily meals, what sliding‑scale correction insulin dosing should be used?

Sliding‑Scale Insulin Dosing for a 70‑Year‑Old Diabetic Patient on Humalog U‑100 Pen (6–14 Units TID Before Meals)

Sliding‑scale insulin as monotherapy is explicitly condemned by all major diabetes guidelines and should be immediately discontinued in favor of a scheduled basal‑bolus regimen.

The American Diabetes Association and other guideline societies state that sliding‑scale insulin (SSI) used alone reacts to hyperglycemia after it occurs rather than preventing it, leading to dangerous glucose fluctuations and poor outcomes. Only approximately 38 % of patients achieve mean glucose < 140 mg/dL with SSI alone, versus 68 % with a scheduled basal‑bolus approach 1. Sliding‑scale monotherapy is not a safe or effective insulin strategy 2, 1.

---

Immediate Regimen Restructuring Required

Discontinue Sliding‑Scale Monotherapy

• Stop using Humalog as correction‑only insulin immediately and transition to a scheduled basal‑bolus regimen 2, 1.
• Correction doses must supplement—not replace—scheduled basal and prandial insulin 2.

Initiate Scheduled Basal Insulin

• Start a long‑acting basal insulin (glargine, detemir, or degludec) at 10 units once daily at bedtime (or 0.1–0.2 units/kg/day for a 70‑kg patient ≈ 7–14 units) 2, 3.
• Basal insulin provides continuous background coverage to suppress hepatic glucose production between meals and overnight 2.

Establish Scheduled Prandial Insulin (Humalog)

• Administer 4–6 units of Humalog 0–15 minutes before each of the three main meals as scheduled prandial insulin 2, 4.
• This dose represents approximately 10 % of a typical basal dose or a standard starting point for prandial coverage 2.
• The current "6–14 units TID" range suggests the patient is already receiving prandial insulin but without basal coverage, which is fundamentally inadequate 2, 1.

---

Correction Insulin Protocol (Adjunct to Scheduled Doses)

Simplified Sliding‑Scale for Correction (In Addition to Scheduled Prandial Insulin)

• Add 2 units of Humalog for pre‑meal glucose > 250 mg/dL (13.9 mmol/L) 2.
• Add 4 units of Humalog for pre‑meal glucose > 350 mg/dL (19.4 mmol/L) 2.
• These correction doses are given on top of the scheduled 4–6 units prandial dose, not as a replacement 2.

Individualized Correction Using Insulin Sensitivity Factor (ISF)

• Calculate ISF = 1500 ÷ total daily insulin dose (TDD) for rapid‑acting analogs like Humalog 2.
• Correction dose = (Current glucose – Target glucose) ÷ ISF 2.
• Example: If TDD = 30 units, ISF = 1500 ÷ 30 = 50 mg/dL per unit. For a pre‑meal glucose of 300 mg/dL with a target of 120 mg/dL, correction = (300 – 120) ÷ 50 = 3.6 units (round to 4 units) 2.

---

Titration Protocols

Basal Insulin Titration

• Increase basal insulin by 2 units every 3 days if fasting glucose is 140–179 mg/dL 2, 3.
• Increase basal insulin by 4 units every 3 days if fasting glucose ≥ 180 mg/dL 2, 3.
• Target fasting glucose: 80–130 mg/dL 2, 3.
• Stop basal escalation when the dose approaches 0.5 units/kg/day (≈ 35 units for a 70‑kg patient) and focus on prandial insulin instead to avoid "over‑basalization" 2.

Prandial Insulin (Humalog) Titration

• Increase each meal dose by 1–2 units (≈ 10–15 %) every 3 days based on the 2‑hour post‑prandial glucose reading 2, 4.
• Target post‑prandial glucose: < 180 mg/dL 2.
• If unexplained hypoglycemia (< 70 mg/dL) occurs, reduce the implicated dose by 10–20 % immediately 2, 3.

---

Monitoring Requirements

• Daily fasting glucose to guide basal insulin adjustments 2, 3.
• Pre‑meal glucose before each meal to calculate correction doses 2.
• 2‑hour post‑prandial glucose after each meal to assess prandial insulin adequacy 2.
• Bedtime glucose to evaluate overall daily pattern 2.
• Reassess insulin doses every 3 days during active titration 2, 3.
• HbA1c every 3 months until stable control is achieved 2.

---

Expected Clinical Outcomes

• With a properly implemented basal‑bolus regimen, approximately 68 % of patients achieve mean glucose < 140 mg/dL, compared with 38 % on sliding‑scale alone 2, 1.
• HbA1c reductions of 2–3 % are achievable within 3–6 months with intensive insulin titration 2.
• Properly executed basal‑bolus therapy does not increase overall hypoglycemia incidence compared with inadequate sliding‑scale approaches 2, 1.

---

Critical Pitfalls to Avoid

• Do not continue sliding‑scale insulin as monotherapy; it is inferior and unsafe 2, 1.
• Do not delay adding basal insulin when glucose repeatedly exceeds 180 mg/dL; prolonged hyperglycemia increases complication risk 2.
• Never use Humalog at bedtime as a sole correction dose, as this markedly raises nocturnal hypoglycemia risk 2.
• Do not increase basal insulin beyond 0.5–1.0 units/kg/day without addressing post‑prandial hyperglycemia, to prevent over‑basalization and hypoglycemia 2.
• Do not rely solely on correction doses without adjusting scheduled basal and prandial insulin 2.

---

Hypoglycemia Management

• Treat any glucose < 70 mg/dL immediately with 15 g of fast‑acting carbohydrate (e.g., 4 glucose tablets or 4 oz juice), recheck in 15 minutes, and repeat if needed 2.
• If hypoglycemia occurs without an obvious cause, reduce the implicated insulin dose by 10–20 % before the next administration 2, 3.

---

Adjunctive Therapy Considerations

• Continue metformin at the maximum tolerated dose (up to ≈ 2,500 mg/day) when using insulin; metformin reduces total insulin requirements by 20–30 % and improves glycemic control 2, 5.
• Discontinue sulfonylureas when initiating basal‑bolus insulin to avoid additive hypoglycemia risk 2.

---

Summary Algorithm

1. Discontinue sliding‑scale monotherapy immediately 2, 1.
2. Start basal insulin (glargine/detemir/degludec) at 10 units once daily at bedtime 2, 3.
3. Give scheduled Humalog 4–6 units 0–15 minutes before each meal 2, 4.
4. Add correction doses (2 units for glucose > 250 mg/dL, 4 units for > 350 mg/dL) on top of scheduled prandial insulin 2.
5. Titrate basal insulin by 2–4 units every 3 days based on fasting glucose 2, 3.
6. Titrate prandial insulin by 1–2 units every 3 days based on 2‑hour post‑prandial glucose 2.
7. Monitor fasting, pre‑meal, post‑prandial, and bedtime glucose daily 2.
8. Reassess every 3 days during titration and every 3 months with HbA1c 2.